Global Preventive
Vaccines Market by Roots Analysis




Although vaccines were solely responsible for the global
eradication of smallpox (1980) and polio (2015), several vaccine-preventable
diseases, such as measles and mumps, are still a threat; COVID-19 has been
recently added to the list





Roots Analysis is pleased to announce the publication of its recent
study, titled, “Global Preventive
Vaccines Market, 2020-2030”.





The report features an extensive study of the current
market landscape and future opportunities associated with the preventive
vaccine domain. The study also features a detailed analysis of the key drivers
and trends related to this evolving segment of the pharmaceutical industry.
Amongst other elements, the report includes:


§
A detailed assessment of the current market landscape,
featuring clinical-stage preventive vaccines.


§
A competitiveness analysis of preventive vaccine developers,
featuring insightful pictorial summaries and representations.


§
Elaborate profiles of the key preventive vaccine developers
(shortlisted based on a proprietary criterion) across North America, Europe and
Asia Pacific.


§
An in-depth analysis of the completed, ongoing and planned
trials of various preventive vaccines.


§
An overview of the ongoing vaccine development initiatives
for complex conditions, such as COVID-19, Ebola virus disease, HIV/AIDS,
malaria and zika virus infection.


§
An analysis of the investments made in this domain, during
the period between 2015 and 2020 (till March).


§
A case study on contract manufacturing landscape for
vaccines, featuring the CMOs engaged in this domain.


§
A detailed market forecast, featuring analysis of the
current and projected future opportunity across key market segments (listed
below)





To request for sample - https://www.rootsanalysis.com/reports/318/request-sample.html





§
Route of Administration


§
Intramuscular


§
Subcutaneous


§
Oral


§
Intravenous


§
Others





§
Type of Vaccine


§
Pneumococcal Conjugate Vaccine


§
Human Papilloma Virus Vaccine


§
Rotavirus Vaccine


§
Influenza Vaccine


§
MMR Vaccine


§
Tetanus and Diphtheria Booster Vaccine


§
Varicella Vaccine


§
DTaP-Hib-IPV Vaccine


§
DTaP-HepB-Hib-IPV Vaccine


§
Others





§
Type of Vaccine API


§
Live, Attenuated Vaccine


§
Inactivated Vaccine


§
Conjugate Vaccine


§
Subunit Vaccine


§
Toxoid Vaccine


§
Others


§
Target Patient Population


§
Pediatric Patients


§
Adults





§
Key Players


§
GlaxoSmithKline


§
Merck


§
Sanofi Pasteur


§
Pfizer


§
Emergent BioSolutions


§
CSL


§
Others





§
Key Geographical Regions


§
North America


§
Europe


§
Asia Pacific


§
Rest of the World





Key
companies covered in the report


§
Bio Farma


§
Emergent BioSolutions


§
GC Pharma


§
GlaxoSmithKline


§
Janssen


§
Merck


§
Novavax


§
Pfizer


§
Sanofi Pasteur


§
Valneva





For
more information please click on the following link:


https://www.rootsanalysis.com/reports/view_document/preventive-vaccines/318.html





Other Recent Offerings


§ Novel
coronavirus (COVID-19): Preventive Vaccines,
Therapeutics
and Diagnostics in Development


§ Novel
Vaccine Delivery Devices Market, 2019-2030 [COVID-19 SERIES]


§ Vaccine
Contract Manufacturing Market (2nd Edition), 2019-2030
[COVID-19 SERIES]





About Roots Analysis


Roots Analysis is one of the fastest growing
market research companies, sharing fresh and independent perspectives in the
bio-pharmaceutical industry. The in-depth research, analysis and insights are
driven by an experienced leadership team which has gained many years of significant
experience in this sector. If you’d like help with your growing business needs,
get in touch at info@rootsanalysis.com





Contact Information


Roots
Analysis Private Limited


Gaurav Chaudhary


+1 (415) 800 3415


ben.johnson@rootsanalysis.com


Facebook - https://www.facebook.com/RootsAnalysis


LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter
- https://twitter.com/RootsAnalysis